Delivery Order SPE2DB24D2205-SPE2DB25FDTXL

Award Date 11/8/24
Potential Completion Date 11/12/24
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, valued at $2,895.45. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a wide...
This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS, valued at $50,393.66. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of May 9, 2023 and is a Firm Fixed Price delivery order. This contract award is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, valued at $20,290.20. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 9, 2022 by the Defense Logistics Agency (DLA). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of...
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the provision of RABAVERT rabies vaccine with diluents to the U.S. government. The $53,477.69 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government, including the Department of Defense (DoD) and Veterans Affairs (VA). This award is part of a larger Indefinite Delivery Contract...
This federal contract award, valued at $1,665.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT Rabies Vaccine with diluents, a critical medical commodity used to prevent rabies infection. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS, valued at $1,940.37, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract has an ultimate completion date of November 13, 2024, and is structured as a firm fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award is for the delivery of RABAVERT rabies vaccine with diluents, placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp as the prime contractor. The firm-fixed-price delivery order has a ceiling value of $3,860.60 and a completion date of November 7, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of RABAVERT RABIES VACCINE WITH DILUENTS to the U.S. Defense Logistics Agency (DLA). The $3,860.60 firm fixed price contract was awarded to the Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor that holds several large indefinite delivery contracts (IDCs) with the DLA and other federal agencies. The contract has no set-aside designation and is a delivery order awarded under Amerisourcebergen's...
This federal contract award, valued at $2,476.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT Rabies Vaccine with diluents, a critical medical product for federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is for the delivery of the RABAVERT rabies vaccine with diluents to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $1,421.72, was awarded to the Corporate Office Division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a firm-fixed price delivery order with a completion date of July 15, 2024. This award is a part of Amerisourcebergen's larger Indefinite...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDTXL
    Delivery Order

This federal contract award is for the delivery of RABAVERT Rabies Vaccine with diluents, valued at $1,219.60. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. The award is associated with the DLA's medical supply procurement efforts, providing critical vaccines and other essential medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/7/25, 9:03 AM